Speaker

Max Wang

Business Development Professional, Fapon Biopharma

Max Wang, Business Development Professional at Fapon Biopharma, is speaking at 2nd T-Cell Engager for Autoimmune Disease Summit (Boston, United States of America, 27–29 Oct 2026) in the session “Optimizing Multi-Targeted Immune Cell Depletion with FP014 to Enhance Therapeutic Window, Efficacy & Long-Term Disease Control”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

2nd T-Cell Engager for Autoimmune Disease Summit
27–29 Oct 2026Boston, United States of America
- SpeakerOptimizing Multi-Targeted Immune Cell Depletion with FP014 to Enhance Therapeutic Window, Efficacy & Long-Term Disease Control

More speakers at 2nd T-Cell Engager for Autoimmune Disease Summit

Mike Jones
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Giovanni Abbadessa
Chief Medical Officer, ModeX Therapeutics
Patrick Baeuerle
Chief Scientific Advisor & Chairman of Scientific Advisory Board, Cullinan Therapeutics, Inc.
Xingfeng Bao
Senior Vice President & Head of Research, GV20 Therapeutics LLC
Alexander Boches
Chief Business Officer, NovalGen
Elaine Chen
Senior Scientist, Translational Biology, Rondo Therapeutics

See all 21 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Max Wang, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].